A chatbot might return a single response based on an editorial or opinion piece it "remembers," presenting it as definitive.

Despite major advances in dermatology, psoriasis continues to pose diagnostic and therapeutic challenges, often requiring ...

Overview of the Digital Pathology MarketThe global Digital Pathology Market is projected to register a growth rate of approximately 10.5% by 2029. The increasing burden of chronic diseases such as ...

Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.

A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and ...

Artificial intelligence (AI) for science has rapidly gained momentum at an extreme pace. Models trained on the scientific record are generating hypotheses and even running experiments in automated ...

The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...

CRISPR gives us the power to rewrite DNA, while AI accelerates that power beyond human control. Together, they’ve launched a genetic arms race that could redefine life—or erase it entirely.

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...